DIrect Effect of DPP-4 inhibitor on HbA1c levels and Renal Dysfunction - DIrect Effect of DPP-4 inhibitor and Renal Dysfunction

Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University0 sites120 target enrollmentOctober 18, 2013

ConditionsType 2 diabetes

Overview

Phase: 未知
Intervention: Not specified
Conditions: Type 2 diabetes
Sponsor: Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University
Enrollment: 120
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

HbA1c reduction of teneligliptin and sitagliptin in 24-weeks was -0.69% and -0.65%, respectively, with no significant difference between the two groups.

Registry

who.int

Start Date

October 18, 2013

End Date

March 31, 2016

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\. Pregnancy 2\. Patients to whom contraindications in the Package Insert apply 3\. Patients whose participation in the study is judged to be difficult for reasons such as reduced ability to understand, unstable mental state, and alcoholism 4\. The patients with type 1 diabetes mellitus and secondary diabetes 5\. Patients treated with insulin and oral hypoglycemic agents except SUs and BGs for more than 3 months 6\. Patients who have concomitant malignant tumors, or who have been treated for malignant tumors within the past 5 years 7\. Foreigners, patients belonging to Kyoto University and/or Kyoto University Hospital, patients who is participating clinical trials 8\. Other patients whose participation is judged to be inappropriate by the responsible physician